CONSERVATIVE SURGERY AND RADIOTHERAPY FOR EARLY BREAST-CANCER

被引:0
|
作者
HARRIS, JR
RECHT, A
CONNOLLY, J
CADY, B
COME, S
HENDERSON, IC
KOUFMAN, C
LOVE, S
SCHNITT, S
OSTEEN, R
机构
[1] NEW ENGLAND DEACONESS HOSP, DEPT SURG, BOSTON, MA 02215 USA
[2] BETH ISRAEL HOSP, DEPT MED, BOSTON, MA 02215 USA
[3] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, CTR BREAST EVALUAT, BOSTON, MA 02115 USA
[4] HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DEPT SURG, BOSTON, MA 02115 USA
[5] BETH ISRAEL HOSP, DEPT RADIAT THERAPY, BOSTON, MA 02215 USA
[6] BETH ISRAEL HOSP, DEPT PATHOL, BOSTON, MA 02215 USA
关键词
D O I
10.1002/1097-0142(19900915)66:14+<1427::AID-CNCR2820661420>3.0.CO;2-W
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In 1984, as part of a prior American Cancer Society National Conference on Breast Cancer, the authors reported on the status of conservative surgery (CS) and radiotherapy (RT) as primary local treatment for women with early stage breast cancer.1 Since that time, additional data have become available regarding the use of this approach and its comparability to mastectomy. In general, these data support the use of CS and RT and, as a result, this approach is now more widely employed in the United States and abroad than it was in 1984. The current focus of inquiry has shifted from whether or not CS and RT is an acceptable option for patients with early stage breast cancer to the following questions. For which patients are CS and RT suitable? What are the best techniques of surgery and RT? Are there any patients who can be treated safely with CS without RT? How should RT and systemic therapy be integrated when both are to be used? In this report, recent results on the use of CS and RT from both retrospective and prospective trials are summarized, and these current areas of inquiry are addressed. Cancer 66:1427‐1438, 1990. Copyright © 1990 American Cancer Society
引用
收藏
页码:1427 / 1438
页数:12
相关论文
共 50 条